Læknablaðið : fylgirit - 05.01.2015, Side 32

Læknablaðið : fylgirit - 05.01.2015, Side 32
X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2 32 LÆKNAblaðið/Fylgirit 82 2015/101 E 76 Rise in hypertensive disorders of pregnancy during the first year after a national economic collapse Védís H. Eiríksdóttir1, Unnur A. Valdimarsdóttir1,2, Tinna L. Ásgeirsdóttir3, Sigrún H. Lund1, Arna Hauksdóttir1, Helga Zoëga1 1Centre of Public Health Sciences, University of Iceland, 2Department of Epidemiology, Harvard School of Public Health, 3Department of Economics, University of Iceland vedis.helga@gmail.com Introduction: Previous research indicates that stress may play a role in the development of hypertensive disorders of pregnancy (HDP), including gestational hypertension (GH) and preeclampsia (PE). The 2008 Icelandic economic collapse represented a powerful stressor that caused increased level of stress among Icelandic women. The aim of the study was to assess whether the prevalence of HDP was elevated in the years following the economic collapse as compared with the years before the crisis. Methods and data: Women giving birth to live-born singletons in Iceland from 2005-2012 constitute the study population. Women‘s information of the use of antihypertensive drugs during pregnancy, including β-blockers and calcium channel blockers, was obtained from the Icelandic Medicines Registry. We used logistic regression analysis to estimate adjusted odds ratios (aOR) and corresponding 95% confidence intervals (CI) of HDP and redemption of antihypertensives by exposure to calendar time of the economic collapse, adjusting for aggregate economic indicators. Results: Compared with preceding years, we observed an increased odds of GH in the first year following the economic collapse (aOR=1.47, 95% CI [1.13-1.91]). Similarly, there was an increase in redemption of β-blockers in the first year following the collapse (aOR=1.43, 95% CI [1.07-1.90]). The observed associations attenuated when adjusting for aggregate unemployment rate (aOR=1.04, 95% CI [0.74-1.47]). No changes were observed for PE or calcium channel blockers. Conclusions: The results suggest an increase in GH and in redemption of β-blockers in the first year following the collapse. This increase may be explained by an increase in the national unemployment rate. E 77 Cognitive function in MS and its relation with physical ability, fatigue and depression Sólveig Jónsdóttir¹,², Hilmar P. Sigurðsson¹, Haukur Hjaltason¹,², Sóley Þráinsdóttir¹,² ¹Department of Neurology, Landspítali University Hospital, ²Faculty of Medicine, University of Iceland soljonsd@landspitali.is Introduction: Cognitive impairment is believed to affect approximately half of patients with multiple sclerosis (MS). The objective of this study was to evaluate cognitive function and its association with physical abi- lity, gender, fatigue and depression in Icelandic patients with relapsing remitting multiple sclerosis (RRMS). Methods and data: A total of 64 RRMS patients about to undergo treat- ment with natalizumab (Tysabri) and 24 sex- and age-matched healthy controls (HCs) participated in the study. Physical ability of patients was evaluated using the Expanded Disability Status Scale (EDSS). All participants underwent an extensive neuropsychological evaluation. Fatigue and depression in patients was also assessed. Results: The RRMS patients scored significantly lower than HCs on most cognitive domains. Greatest deficits were observed on psycho- motor speed. Verbal and visuospatial learning and memory, verbal and visuospatial fluency and linguistic skills were also impaired. Visuospatial reasoning ability was spared. The EDSS score (mean 3.5) was significantly related to cognitive measures that did not require any physical ability. When controlling for hand dexterity, approximately 53% of the patients were considered cognitively impaired. Males were more impaired than females. Severe fatigue was experienced by 81.3% of the patients and 45.3% suffered from depression. Fatigue and depress- ion had no effect on cognitive function. Conclusions: Impaired cognitive function can have serious effects on the quality of life and employability of RRMS patients and needs to be detected early in the disease process as it may affect treatment decisions. More studies are needed on methods to improve cognitive function and prevent further decline in patients with RRMS. E 78 Parental longevity and survival in patients with multiple myeloma and MGUS Ingigerður Sólveig Sverrisdóttir1, Sigrún Helga Lund2, Sigurður Yngvi Kristinsson3,4 1Landspítali University Hospital, 2Department of Public Health, Faculty of Medicine, University of Iceland, 3Faculty of Medicine, University of Iceland, 4Department of Hematology, Landspítali University Hospital ingigerdursverrisdottir@gmail.com Introduction: In the general population, parental longevity is associated with an increased life expectancy. There are limited data focusing on host characteristics and their effect on survival among multiple mye- loma (MM) patients and its precursor, MGUS. Our aim was to study the impact of parental longevity on survival among MM and MGUS patients. Methods and data: A total of 1,815 patients with MM, 1,407 MGUS patients as well as 8,267 population-based controls for MM patients and 5,595 controls for MGUS were included in the study. We compared the risk of death among MM and MGUS patients with a history of parental longevity to those patients without a long-lived parent. Results: Among MM patients, a history of parental longevity was not associated with a decreased risk of death (HR=0.92; 95% CI 0.81-1.05). Having one long-lived parent or both did not have an effect (HR=0.91; 95% CI 0.80-1.04 and HR=1.02; 95% CI 0.72-1.47, respectively). A history of parental longevity among MGUS patients was associated with a significant decrease in risk of death (HR=0.69; 95% CI 0.53-0.91). The risk of death decreased when one parent was long-lived (HR=0.69; 95% CI 0.52-0.91). However, based on few numbers, when both parents were long-lived the risk of death was not significantly affected (HR=0.72; 95% CI 0.34-1.53). Conclusions: Parental longevity does not predict survival in MM patients. For MGUS patients, however, the impact of longevity is similar to controls, with superior survival among those with long-lived parents. E 79 Prediagnostic serum 25 hydroxyvitamin D and total mortality of men diagnosed with prostate cancer Jóhanna Eyrún Torfadóttir1,2, Laufey Steingrímsdóttir2, Thor Aspelund1,4, Laufey Tryggvadóttir5, Þórhallur I. Halldórsson2, Vilmundur Guðnason 4,6 Unnur A. Valdimarsdóttir1,3 1Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, 2Unit for Nutrition Research, Faculty for Food Science and Nutrition, University of Iceland, 3Department of Epidemiology, Harvard School of Public Health, 4The Icelandic Heart Association, 5The Icelandic Cancer Registry, 6Faculty of Medicine, University of Iceland jet@hi.is Introduction: Limited data are available on the effect of vitamin D
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104
Side 105
Side 106
Side 107
Side 108
Side 109
Side 110
Side 111
Side 112
Side 113
Side 114
Side 115
Side 116
Side 117
Side 118
Side 119
Side 120
Side 121
Side 122
Side 123
Side 124
Side 125
Side 126
Side 127
Side 128
Side 129
Side 130
Side 131
Side 132
Side 133
Side 134
Side 135
Side 136
Side 137
Side 138
Side 139
Side 140
Side 141
Side 142
Side 143
Side 144
Side 145
Side 146
Side 147
Side 148
Side 149
Side 150
Side 151
Side 152
Side 153
Side 154
Side 155
Side 156
Side 157
Side 158
Side 159
Side 160
Side 161
Side 162
Side 163
Side 164
Side 165
Side 166
Side 167
Side 168
Side 169
Side 170
Side 171
Side 172
Side 173

x

Læknablaðið : fylgirit

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.